← All compounds
peptide40 listings
Tesofensine
Triple Monoamine Reuptake Inhibitor
Triple monoamine reuptake inhibitor researched for metabolic outcomes.
Metabolic researchAppetite research
/ research index
The research base
Research Maturity
★★★☆☆
3/5 — Volume of studies
Evidence Strength
★★★★☆
4/5 — Quality of evidence
Phase 2 trials show strong metabolic effects.
/ mechanism of action
How it works
Inhibits reuptake of dopamine, norepinephrine, and serotonin.
/ research dosing
Common research protocols
Range
0.25 → 0.5 → 1.0 mg/day (titration)
Frequency
Once daily, morning
Route
Oral capsule
Cycle
Phase 2 trials ran 24 weeks
Research notes
Triple monoamine reuptake inhibitor (norepinephrine, serotonin, dopamine). Start low (0.25mg/day) to assess cardiovascular response. Heart rate and BP elevation common. Phase 2 trials titrated to 1mg/day max.
References
FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.
/ standalone use
As a solo compound
Standalone use is the research norm.
/ side effects
What to know
Possible heart rate elevation, dry mouth.
/ timeline
Realistic expectations
4-8 weeks
/ recommendation
Where to buy Tesofensine
🏆Our pick for Tesofensine
Valor Peptides
10mg · USA · Card / Crypto
- ✓Third-party tested (Janoshik)
- ✓COAs provided — Comprehensive
- ✓Highest verification tier in stock
- ✓4.8★ community rating
Also solid
/ all listings
Full index, price per mg
Supplier
Trust Score
Size
Price
$/mg
Stock
Buy
FOR RESEARCH USE ONLY. Tesofensine is intended for laboratory research and not for human consumption.